HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Azhar R Hussain Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

2/2014Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
1/2013Phosphorylated IκBα predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release.
7/2012Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
7/2011The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
1/2011Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.
9/2010Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma.
7/2010Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma.
5/2010Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma.
12/2006Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Azhar R Hussain Research Topics

Disease

27Neoplasms (Cancer)
09/2017 - 10/2005
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2014 - 12/2006
8Colorectal Neoplasms (Colorectal Cancer)
07/2015 - 05/2008
6Primary Effusion Lymphoma
01/2012 - 04/2005
4Lymphoma (Lymphomas)
02/2014 - 10/2008
4Papillary Thyroid Cancer
03/2012 - 10/2008
3Carcinogenesis
02/2014 - 05/2010
2Ovarian Epithelial Carcinoma
05/2015 - 10/2009
2Obesity
02/2014 - 11/2009
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2013 - 01/2012
2Thyroid Neoplasms (Thyroid Cancer)
01/2011 - 01/2011
1COVID-19
01/2023
1Infections
01/2023
1Breast Neoplasms (Breast Cancer)
09/2017
1Necrosis
07/2010
1Carcinoma (Carcinomatosis)
11/2009
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2008
1Kaposi Sarcoma (Kaposi's Sarcoma)
04/2005

Drug/Important Bio-Agent (IBA)

6Phosphotransferases (Kinase)IBA
02/2014 - 05/2010
5Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
09/2017 - 01/2011
5Bortezomib (Velcade)FDA Link
02/2014 - 05/2008
4Leptin ReceptorsIBA
02/2014 - 11/2009
4LeptinIBA
02/2014 - 11/2009
3Proteins (Proteins, Gene)FDA Link
07/2012 - 04/2005
35- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
03/2012 - 01/2011
3LigandsIBA
03/2012 - 07/2010
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2011 - 09/2010
3Fatty Acid Synthases (Fatty Acid Synthase)IBA
05/2010 - 10/2008
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2009 - 04/2005
3Protein Kinases (Protein Kinase)IBA
10/2009 - 05/2008
2Biomarkers (Surrogate Marker)IBA
01/2023 - 07/2011
2embelinIBA
09/2017 - 07/2015
2Cisplatin (Platino)FDA LinkGeneric
05/2015 - 01/2011
2Calcibiotic Root Canal SealerIBA
02/2014 - 11/2009
2thymoquinoneIBA
01/2013 - 04/2011
2Thiostrepton (Gargon)IBA
07/2012 - 01/2012
2Proto-Oncogene Proteins c-metIBA
03/2012 - 01/2011
2X-Linked Inhibitor of Apoptosis ProteinIBA
01/2012 - 10/2010
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
12/2011 - 07/2010
2EnzymesIBA
05/2010 - 07/2009
2Proteasome Endopeptidase Complex (Proteasome)IBA
10/2009 - 05/2008
2UbiquitinIBA
10/2009 - 05/2008
2CurcuminIBA
10/2008 - 10/2005
2Phosphatidylinositols (Phosphatidylinositol)IBA
12/2006 - 04/2005
1Messenger RNA (mRNA)IBA
01/2023
1Interferon LambdaIBA
01/2023
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
09/2017
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2015
1Mechanistic Target of Rapamycin Complex 1IBA
07/2014
1Mechanistic Target of Rapamycin Complex 2IBA
07/2014
1Tumor Biomarkers (Tumor Markers)IBA
07/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2012
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2012
1Transcription Factors (Transcription Factor)IBA
01/2012
1Matrix Metalloproteinases (MMPs)IBA
01/2012
1CyclinsIBA
05/2011
1Ubiquitin-Conjugating EnzymesIBA
05/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2011
1ResveratrolIBA
01/2011
1DecitabineFDA Link
01/2011
1Inhibitor of Apoptosis ProteinsIBA
10/2010
1Death Domain ReceptorsIBA
07/2010
1CytokinesIBA
07/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2010
1Fatty Acids (Saturated Fatty Acids)IBA
05/2010
1AdipokinesIBA
11/2009
1Proteasome InhibitorsIBA
07/2009
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
07/2009
1Phospholipids (Phosphatides)FDA LinkGeneric
07/2009
1NF-kappa B (NF-kB)IBA
10/2008
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2008
1sanguinarineIBA
04/2007

Therapy/Procedure

4Drug Therapy (Chemotherapy)
02/2014 - 04/2007
2Therapeutics
07/2015 - 07/2010